Metabolic syndrome and the risk of Barrett's oesophagus in white males

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 11, 2015, Pages 1182-1189

  Thrift, A P ^a   Hilal, J ^a   El Serag, H B ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b VA HSRandD Houston Center of Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; CAUCASIAN; COLONOSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; WAIST HIP RATIO; AGED; COMPLICATION; DIGESTIVE TRACT ENDOSCOPY; MIDDLE AGED; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL;

AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; RISK FACTORS;

EID: 84929094478     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13176     Document Type: Article

References (26)

1. Thrift AP, Whiteman DC,. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-62.
2. Howlader N, Noone A, Krapcho M, et al,. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute. Based on November 2013 SEER data submission, posted to the SEER website, April 2014, http://seer.cancer.gov/csr/1975-2011/.
3. Shaheen N, Ransohoff DF,. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 2002; 287: 1972-81.
4. Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB,. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol 2013; 108: 915-22.
5. Thrift AP, Shaheen NJ, Gammon MD, et al,. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst 2014; 106: dju252.
6. Kubo A, Cook MB, Shaheen NJ, et al,. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut 2013; 62: 1684-91.
7. El-Serag HB, Hashmi A, Garcia J, et al,. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut 2014; 63: 220-9.
8. Lagergren J,. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011; 8: 340-7.
9. Cowey S, Hardy RW,. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006; 169: 1505-22.
10. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D,. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012; 35: 2402-11.
11. Healy LA, Ryan AM, Pidgeon G, Ravi N, Reynolds JV,. Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease. Dis Esophagus 2010; 23: 386-91.
12. Drahos J, Ricker W, Parsons R, Pfeiffer RM, Warren JL, Cook MB,. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare data. J Clin Gastroenterol 2015; 49: 282-8.
13. Leggett CL, Nelsen EM, Tian J, et al,. Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc 2013; 88: 157-65.
14. Rubenstein JH, Morgenstern H, McConell D, et al,. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterology 2013; 145: 1237-44.e1-5.
15. Iyer PG, Borah BJ, Heien HC, Das A, Cooper GS, Chak A,. Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol 2013; 11: 1108-14 e5.
16. Kramer JR, Fischbach LA, Richardson P, et al,. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol 2013; 11: 373-81.
17. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR,. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
19. Thrift AP, Kramer JR, Alsarraj A, El-Serag HB,. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol 2014; 48: 218-23.
20. Abdallah J, Maradey-Romero C, Lewis S, Perzynski A, Fass R,. The relationship between length of Barrett's oesophagus mucosa and body mass index. Aliment Pharmacol Ther 2015; 41: 137-44.
21. Anggiansah R, Sweis R, Anggiansah A, Wong T, Cooper D, Fox M,. The effects of obesity on oesophageal function, acid exposure and the symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2013; 37: 555-63.
22. Gudlaugsdottir S, Verschuren W, Dees J, Stijnen T, Wilson J,. Hypertension is frequently present in patients with reflux esophagitis or Barrett's esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med 2002; 13: 369.
23. Greer KB, Thompson CL, Brenner L, et al,. Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut 2012; 61: 665-72.
24. Garcia JM, Splenser AE, Kramer J, et al,. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol 2014; 12: 229-38.
25. Moki F, Kusano M, Mizuide M, et al,. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007; 26: 1069-75.
26. Hsu CS, Wang PC, Chen JH, et al,. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011; 34: 994-1004.